BOCA RATON, Fla., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Emergent Health Corp. (Pink Sheets:EMGE) announced today the appointment of three new members to its Board of Directors. Joining the Board of Directors are David P. Jones, Ph.D., M. Scott Maguire, MBA, and Robert S. McCoy, Jr. "We are delighted to announce the addition of our three newest Board members. All three embody the spirit of Emergent bringing talent, expertise and energy to the table. We are very fortunate to have them by our side," said Dr. John V. Cappello, Founder, and former President and Chief Executive Officer for Emergent.
David P. Jones, Ph.D. has practiced as a business psychologist and human resources consultant for over 30 years. He serves as President of Growth Ventures Inc., a human capital advisory firm working with start-up and established companies, as well as units of government, to guide implementation of systems for talent acquisition, development, retention, and legal compliance.
Prior to founding Growth Ventures, Inc., Dr. Jones was the worldwide head of human resources and change management consulting services with today's Aon-Hewitt Consulting Worldwide; one of the world's largest human resources advisory firms. Before that, he founded and served as Chairman and CEO of HRStrategies, a human resources consulting and outsourcing firm with offices throughout the U.S. and Europe. HR Strategies was listed among the fastest growing consulting companies in the U.S. prior to its 1995 acquisition by Aon-Hewitt.
Dr. Jones has worked with most of the Fortune 500 companies and units of government in the design and implementation of competency modeling, employee assessment and screening programs for both entry-level hiring and promotional decision-making. He was a pioneer in the application of technology solutions to competency modeling, recruitment, assessment, and selection program delivery in the 1990s, introducing such programs in both the United States and internationally; particularly in high-volume start-up settings.
In addition to designing and implementing HR strategic planning, employee selection, performance management, management development, and retention programs, Dr. Jones serves as an expert witness in matters associated with legal compliance in areas associated with the Uniform Guidelines on Employee Selection Procedures, Executive Order 11246, the Americans with Disability Act, the Equal Pay Act, the Fair Labor Standards Act, and related statutory requirements. Dr. Jones recently authored the Jossey-Bass release Million Dollar Hire: Build Your Bottom Line, One Employee at a Time to help organizations assemble the strategies and tactics that guide sound recruiting, screening and candidate assessment, while avoiding the legal pitfalls.
M. Scott Maguire, MBA has over 23 years of finance, life science, and healthcare industry expertise. Since 2004 Mr. Maguire is serving as the Chief Executive Officer and Chairman of the Board of Xenetic Biosciences (OTC Markets:XBIO). With his background in life science and healthcare investment banking, Mr. Maguire has advised many US and European companies on capital raisings and commercial development. Mr. Maguire began his banking career with Merrill Lynch in 1987 in New York and, after receiving his MBA in 1993, joined the healthcare division of W.R. Grace National Medical Care, where he helped create the international healthcare division. In 1996, he co-founded the Arthur Andersen global healthcare corporate finance practice based in London.
Mr. Maguire is currently director of Healthcare Capital Partners Limited, a healthcare corporate finance and proprietary investment boutique he co-founded in 2002, and a non-executive director of Renal Services Ltd, a company focused on dialysis service provision in the UK.
Robert S. McCoy, Jr. retired in 2003 as Vice Chairman of Wachovia Corporation after spending two years co-managing the integration of Wachovia and First Union Corporation subsequent to their 2001 merger. From 1992 to 2001, he served as Vice Chairman and Chief Financial Officer of Wachovia Corporation; and from 1984 to 1992, he served as President and Chief Financial Officer of South Carolina National Corporation, which was acquired by Wachovia in 1992. Prior to that time, he had a 23-year career at Price Waterhouse, including as a partner from 1974 to 1984. Since retiring in 2003, Mr. McCoy has chaired the Audit Committee of two public companies, including Krispy Kreme. Mr. McCoy currently serves as Director of MedCath Corporation, a cardiovascular services company, since 2003; and, Director Web.com Group, Inc., a provider of website building tools, internet marketing and lead generation solutions, since 2007.
Mr. McCoy brings to Emergent extensive leadership, risk-management, and financial experience gained in his expansive business career, which included roles as an accountant and as the chief financial officer of two public bank holding companies. His experience in the financial services industry and roles involving integration, risk-management, finance, accounting matters, and preparation of financial statements serve as the basis for Mr. McCoy's contributions to Emergent. Mr. McCoy's financial and accounting expertise is invaluable in his role on the Board and as Chairman of Emergent's Audit Committee. Mr. McCoy qualifies as an "audit committee financial expert" under SEC guidelines.
About Emergent Health Corp.
Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. With patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.
This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors that could cause actual results to differ materially from those estimated by the company. This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.